Cu1. 87Ag0. 13 (Sr0. 06Sn0. 94) Se2S nanosheet, composite scaffold as well as preparation method and application of composite scaffold

Through the combination of Cu1.87Ag0.13 (Sr0.06Sn0.94)Se2S nanosheets and 3D-printed bioactive glass scaffolds, microwave-thermal-electrochemical energy conversion is used to efficiently ablate bone tumors at low temperatures and promote bone repair. The problem of ablation and repair in osteosarcoma treatment is solved and the risk of damage to normal tissue is reduced.

CN119018857APending Publication Date: 2024-11-26SHANGHAI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411145531.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In the treatment of osteosarcoma, it is difficult for the prior art to effectively ablate the tumor and repair bone defects, and microwave thermal therapy is difficult to completely control the tumor during low-temperature ablation, which may lead to unsatisfactory treatment effect and a risk of damage to normal tissues.

Method used

Develop a Cu1.87Ag0.13 (Sr0.06Sn0.94)Se2S nanosheet with microwave response and high-efficiency microwave-thermal conversion performance. It produces reactive oxygen species through energy conversion of microwave-thermal-electrochemical energy, combined with 3D printing Bioactive glass scaffolding to achieve low temperature ablation of bone tumors and promote bone repair.

Benefits of technology

It has achieved efficient ablation of bone tumors at low temperatures, reduced damage to normal tissues, and has anti-infective performance, improved the effect of bone tumor treatment, and promoted the repair and regeneration of bone tissue.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119018857A_ABST
    Figure CN119018857A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of multifunctional tissue engineering biological materials, particularly relates to a Cu1. 87Ag0. 13 (Sr0. 06Sn0. 94) Se2S nanosheet, a composite scaffold and a preparation method and application of the Cu1. 87Ag0. 13 (Sr0. 06Sn0. 94) Se2S nanosheet, and provides a high-entropy thermoelectric material Cu1. 87Ag0. 13 (Sr0. 06Sn0. 94) Se2S nanosheet with microwave thermocatalytic performance and microwave response temperature rise performance, the high-entropy thermoelectric material Cu1. 87Ag0. 13 (Sr0. 06Sn0. 94) Se2S nanosheet has a good microwave heat effect and can be used for preparing a thermoelectric material. Heat energy generated by microwaves can be converted into electric energy and chemical energy, multiple kinds of active oxygen such as hydroxyl free radicals (. OH), singlet oxygen (1O2) and superoxide anions (. O2-) are generated to kill tumor cells, and glutathione (GSH) can be consumed to amplify oxidative damage; the BG scaffold has good biocompatibility and degradability, the composite scaffold is obtained by dispersing the Cu1. 87Ag0. 13 (Sr0. 06Sn0. 94) Se2S nanosheets into pores of the BG scaffold, the composite scaffold can be implanted into a bone defect part for osteogenesis, and meanwhile, the microwave thermocatalytic performance and microwave response temperature rise performance of the Cu1. 87Ag0. 13 (Sr0. 06Sn0. 94) Se2S nanosheets can be utilized to treat bone tumors and prevent postoperative infection. The important significance is realized on bone tumor treatment and bone defect repair.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biomedical materials, specifically to the technical field of multifunctional tissue engineering biomaterials, and more specifically to a Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets, composite scaffolds, and preparation methods and applications thereof. Background Art

[0002] Osteosarcoma is a common primary malignant bone tumor that mainly occurs in the metaphysis of long bones, but can affect any bone in the body. Its pathogenesis is complex, highly heterogeneous and invasive, and has become a major medical challenge. The incidence of osteosarcoma includes children, adolescents and adults. Clinically, surgical resection is one of the effective means to treat bone tumors, but it faces problems such as tumor recurrence after resection and difficulty in repairing large bone defects and infection. Bone transplantation is often used clinically to repair bone defects, such as autologous bone transplantation, allogeneic bone transplantation and xenogeneic bone transplantation, but these methods have limited bone sources, immune rejection and infection risks. Therefore, there is an urgent need to construct a multifunctional tissue engineering biomaterial with the triple functions of "bone metastasis killing", "bone tissue remodeling" and "anti-postoperative infection" to more effectively meet the treatment challenges of osteosarcoma.

[0003] Microwave thermal therapy (MWTT) is a treatment method that kills tumor cells through thermal effects. It takes advantage of the low blood flow and slow flow rate in the tumor site to accumulate heat in a short time and quickly reach the killing temperature, resulting in cell membrane damage, cell metabolism changes and organelle damage, thereby effectively killing tumor cells. MWTT has received widespread attention due to its convenient operation, high heating efficiency and wide heating range. Microwaves, as an electromagnetic wave, resonate when acting on polar molecules such as water molecules, and generate heat through high-speed rotation friction between molecules. Compared with photothermal, ultrasound and other technologies, microwaves have a more efficient heat generation capacity. However, in clinical tumor treatment, in order to avoid damaging normal tissues around the tumor, it is often necessary to reduce the microwave power and achieve low-temperature ablation. However, simple low-temperature ablation is difficult to completely control the tumor, which may lead to unsatisfactory treatment effects.

[0004] In order to improve the therapeutic efficiency of microwave hyperthermia, the commonly used method is to use microwave sensitizers for targeted heating. Microwave sensitizers are a type of nanosystem that can perform microwave-heat conversion. Microwave sensitizers can effectively absorb microwave energy and quickly convert it into heat energy, thereby enhancing the heating effect of local tumor tissue. Due to the low blood flow in tumor tissue, microwave sensitizers can gather more heat, thereby reaching the tumor cell killing temperature in a shorter time. However, since the temperature increase at the tumor site may cause damage to the surrounding normal tissues, it is of great clinical significance to develop a nanodelivery system with excellent microwave-heat conversion performance and combine it with other treatment methods to reduce the side effects of bone tumor treatment. Summary of the invention

[0005] The present invention aims to provide a Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets, composite scaffolds and their preparation methods and applications. The present invention constructs for the first time a high-entropy thermoelectric material with microwave-responsive and efficient microwave thermal conversion. The high-entropy thermoelectric material works synergistically with microwave hyperthermia. After the energy conversion of "microwave-heat-electricity-chemical energy", the microwave-responsive high-entropy thermoelectric material is used as a heat source for thermoelectricity. While achieving low-temperature ablation of bone tumors, a large amount of reactive oxygen species (ROS) is generated through efficient conversion of thermal energy and electrical energy, thereby achieving the purpose of both ablation of bone tumor tissue and bone repair, and having anti-infection properties. At the same time, low-temperature (about 42°C) ablation of bone tumors can avoid damage to the normal tissue around the tumor, which is of great significance for further improving the application effect of materials in the treatment of bone tumors.

[0006] Based on the above purpose, the technical solution adopted by the present invention is as follows:

[0007] In a first aspect, the present invention provides a Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets, which have microwave thermal catalytic properties and microwave responsive heating properties.

[0008] The present invention constructs for the first time a nanosheet Cu with microwave thermal catalytic performance and microwave response heating performance. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S, Cu prepared by the present invention 1.87 Ag 0.13 (Sr 0.06 Sn 0.94) Se2S nanosheets, when the aqueous dispersion concentration is 0.1-1 mg / mL, are treated with microwaves at 4W power for 4 min. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )The temperature of Se2S aqueous dispersion can be increased to 40-46.1°C, showing a higher microwave-to-heat conversion efficiency.

[0009] The Cu that the present invention claims for protection 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S nanosheets are a high-entropy thermoelectric material with thermal catalytic properties and good microwave thermal effect. They can convert the thermal energy generated by microwaves into electrical energy, realize the conversion of microwave-thermal-electrical-chemical energy, and then generate hydroxyl radicals (·OH), singlet oxygen ( 1 O2) and superoxide anion (·O2 - ) and other reactive oxygen species kill tumor cells and can consume glutathione (GSH), amplifying oxidative damage, and playing an important role in bone tumor ablation.

[0010] In addition, Cu in the nanosheets can promote the formation of new blood vessels in bone repair; Ag and Sr have antibacterial properties; Sn plays a role by inhibiting tumor cell proliferation and inducing cell apoptosis, which helps promote the proliferation and differentiation of bone cells and support the regeneration and repair of bone tissue; Se inhibits tumor cell proliferation, induces cell apoptosis and inhibits tumor angiogenesis through multiple mechanisms, promotes the proliferation and mineralization of bone cells, and supports the formation and regeneration of new bone; S is an important component of components such as chondroitin sulfate and keratan sulfate in cartilage and bone matrix, and is essential for the health and repair of cartilage and bone tissue. S also has anti-inflammatory effects, reduces bone tumor-related inflammatory responses, relieves pain and promotes healing. S can also enhance the biocompatibility and bioactivity of the material and promote the attachment and growth of bone cells.

[0011] In a second aspect, the present invention provides a Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) A method for preparing Se2S nanosheets, comprising the following steps:

[0012] S1: dissolving diphenyl diselenide in oleylamine to form solution A;

[0013] S2: Dissolve CuCl, AgNO3, SrCl2·6H2O, SnCl2·2H2O, and dodecanethiol in oleylamine to form solution B;

[0014] S3: After degassing solution B, heat it to 210℃~250℃, add solution A to it and mix well, keep the temperature at 220℃~260℃ for 20~40min, cool and centrifuge to obtain Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets.

[0015] The invention uses diphenyl diselenide, CuCl, AgNO3, SrCl2·6H2O, SnCl2·2H2O and dodecanethiol as raw materials for preparing Se, Cu, Ag, Sr, Sn and S elements in the nanosheets respectively, and mixes and reacts the raw materials at a certain temperature in an oil phase, and the preparation process is simple.

[0016] Preferably, the mass concentration of diphenyl diselenide in solution A is 78 mg / mL.

[0017] Preferably, in solution B, the mass concentration of CuCl is 7 mg / mL; the mass concentration of AgNO3 is 0.83 mg / mL; the mass concentration of SrCl2·6H2O is 0.4 mg / mL; the mass concentration of SnCl2·2H2O is 5.3 mg / mL; and the mass concentration of dodecanethiol is 12.5 wt%.

[0018] Preferably, the volume ratio of solution A to solution B is 1:4.

[0019] In a third aspect, the present invention provides a Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S-BG composite scaffold, the composite scaffold comprising a 3D printed BG scaffold and a Cu loaded on the 3D printed BG scaffold 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets, in which Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )The mass ratio of Se2S nanosheets to 3D printed BG scaffolds is (0.5~4):6.

[0020] Preferably, Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )The mass ratio of Se2S nanosheets to 3D printed BG scaffolds is (1-3):6.

[0021] In a fourth aspect, the present invention provides a Cu 1.87 Ag0.13 (Sr 0.06 Sn 0.94 ) The preparation method of Se2S-BG composite scaffold comprises the following steps:

[0022] The BG support was immersed in the Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets in water dispersion, and then taken out and dried to obtain Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S-BG composite scaffold.

[0023] The present invention adopts the method of immersing the BG support in Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets aqueous dispersion can be used to successfully load Cu on the 3D printed BG scaffold 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets are simple, convenient, widely applicable, and low-cost, so they can be used for large-scale production.

[0024] Preferably, Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) The mass concentration of Se2S nanosheets in the aqueous dispersion of the nanosheets is 0.1-1 mg / mL.

[0025] Preferably, the BG scaffold is prepared by the following method:

[0026] A 10 wt% polyvinyl alcohol sol was prepared with deionized water and heated with magnetic stirring at 90°C and a rotation speed of 200-400 rpm. The polyvinyl alcohol sol and the BG scaffold powder were evenly mixed at a mass ratio of 1:1.2 to obtain printing ink, which was then printed into a BG scaffold blank using a 3D printer. The BG scaffold blank was first dried in an oven at 60°C for 1 hour, and then calcined in a muffle furnace at 1060°C for 3 hours to obtain a 3D printed BG scaffold.

[0027] 3D printed bioactive glass (BG) scaffolds have good biocompatibility and degradability. The Si, Ca, and P elements they contain are essential elements for promoting bone regeneration, and therefore play an increasingly important role in bone tissue regeneration. 1.87 Ag 0.13 (Sr 0.06 Sn0.94 )Se2S nanosheets are dispersed into the pores of the BG scaffold to obtain a composite scaffold Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S-BG can be implanted into bone defects for osteogenesis, and can also be used to 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets for the treatment of bone tumors by utilizing their microwave thermocatalytic properties and microwave responsive heating properties.

[0028] In a fifth aspect, the present invention provides the Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets or Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Application of Se2S-BG composite scaffold in the preparation of drugs for treating bone tumors or bone defect repair materials.

[0029] The present invention Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheet composite scaffolds were prepared by 3D printing bioactive glass (BG) scaffolds loaded with Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets, of which Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets can generate hydroxyl radicals (·OH), singlet oxygen ( 1 O2) and superoxide anion (·O2 - ), etc., and can consume glutathione (GSH), and has a good microwave thermal effect, while the 3D printed BG scaffold has good biocompatibility and degradability, Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S nanosheets can be used to repair bone defects after being combined with 3D printed BG scaffolds. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94)Se2S nanosheets can be used to treat bone tumors by utilizing their microwave thermal catalytic properties and microwave responsive heating properties, thus becoming a dual-functional biomaterial that can treat bone tumors and repair bone defects.

[0030] Compared with the prior art, the present invention has the following beneficial effects:

[0031] The present invention prepares a high entropy thermoelectric material Cu with microwave thermal catalytic performance and microwave response heating performance 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets have good microwave thermal effect and can convert the heat energy generated by microwaves into electrical energy, generating hydroxyl radicals (·OH), singlet oxygen ( 1 O2) and superoxide anion (·O2 - ) and other reactive oxygen species kill tumor cells and can consume glutathione (GSH) to amplify oxidative damage; BG scaffold has good biocompatibility and degradability. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets are dispersed into the pores of the BG scaffold to obtain a composite scaffold, which can be implanted in the bone defect for osteogenesis. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )The microwave thermal catalytic properties and microwave responsive heating properties of Se2S nanosheets are used to treat bone tumors, which is of great significance for the treatment of bone tumors and the repair of bone defects. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 The Cu prepared in Example 1 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )XPS spectrum of Se2S nanosheets;

[0033] Figure 2 The Cu prepared in Example 1 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )TEM image of Se2S nanosheets;

[0034] Figure 3 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) MB degradation curves of Se2S nanosheets at different concentrations;

[0035] Figure 4 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )MB degradation curves of Se2S nanosheets at different temperatures;

[0036] Figure 5 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) ABDA degradation curves of Se2S nanosheets at different concentrations;

[0037] Figure 6 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) ABDA degradation curves of Se2S nanosheets at different temperatures;

[0038] Figure 7 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) NBT degradation curves of Se2S nanosheets at different concentrations;

[0039] Figure 8 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) NBT degradation curves of Se2S nanosheets at different temperatures;

[0040] Fig. 9 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) DTNB degradation curves of Se2S nanosheets at different concentrations;

[0041] Fig.10 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) DTNB degradation curves of Se2S nanosheets at different temperatures;

[0042] Fig.11 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Microwave response heating curves of Se2S nanosheets at different concentrations;

[0043] Fig.12 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Fluorescence spectra of Se2S nanosheets and Cu2SnSe3 nanocrystals;

[0044] Fig.13 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Physical photos and SEM images of Se2S-BG composite scaffolds and blank BG scaffolds;

[0045] Fig.14 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Elemental analysis spectrum of Se2S-BG composite scaffold;

[0046] Fig.15 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) The cell activities of KHOS cells when Se2S nanosheets were co-incubated with them at different concentrations for 12 h and 24 h;

[0047] Fig.16 The figure shows the killing effect of different treatment groups on KHOS tumor cells co-incubated for 12 hours;

[0048] Fig.17 The figure shows the killing effect of different treatment groups on KHOS tumor cells co-incubated for 24 hours;

[0049] Fig.18 The graphs show the ROS levels in KHOS of tumor cells corresponding to different treatment groups;

[0050] Fig.19 CLSM images of KHOS cells after calceinAM / PI staining after different treatments;

[0051] Fig. 20 The KHOS apoptosis rate of tumor cells in different treatment groups;

[0052] Fig.21 The figures are the antibacterial effect diagrams of different treatment groups. DETAILED DESCRIPTION

[0053] In order to better illustrate the purpose, technical scheme and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments. It should be understood by those skilled in the art that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. The test methods used in the examples are conventional methods unless otherwise specified; the materials, reagents, etc. used can be obtained from commercial sources unless otherwise specified.

[0054] Example 1

[0055] This embodiment provides a Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S nanosheets, the preparation method of the nanosheets comprises the following steps:

[0056] S1: 2.341 g of diphenyl diselenide was dissolved in 30 mL of oleylamine at room temperature and ultrasonicated for 15 min to obtain solution A.

[0057] 0.8373 g CuCl, 0.0995 g AgNO3, 0.048 g SrCl2·6H2O, 0.6345 g SnCl2·2H2O, 15 mL dodecanethiol and 120 mL oleylamine were placed in a three-necked flask to obtain solution B. Solution B was degassed at room temperature for 3 min and then purged with nitrogen under magnetic stirring, and the process was repeated three times to form a uniform mixture.

[0058] The uniform mixture was heated to 230°C, solution A was added to the mixture, and the mixture was heated to 240°C for 30 min, cooled to room temperature, and the product was collected by centrifugation to obtain Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets.

[0059] XPS elemental analysis of the nanosheets prepared in this example showed that Figure 1 As shown in the figure, it can be seen that this embodiment successfully prepared Cu containing Cu, Ag, Sr, Sn, Se, S elements. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets.

[0060] The Cu prepared in this example 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets were characterized by TEM, such as Figure 2 As shown, it can be seen that the Cu prepared in this embodiment 1.87 Ag0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets are monolithic structures.

[0061] The Cu prepared in this example 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets were studied for the following properties, including the following five parts:

[0062] 1. Methylene blue (MB) degradation test

[0063] Different concentrations of Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S aqueous solutions (0 μg / mL, 62.5 μg / mL, 125 μg / mL, 250 μg / mL, 500 μg / mL and 1 mg / mL) were mixed with MB (5 μM), heated in a water bath at 65 °C for 15 min, the nanosheets were removed by centrifugation, and the changes in the characteristic absorption peaks of MB at a wavelength of 665 nm were recorded using a UV spectrophotometer.

[0064] The results are as follows Figure 3 As shown, as Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )With the increase of Se2S concentration, the ultraviolet characteristic absorption peak of MB becomes weaker.

[0065] The concentration of Cu was 1 mg / mL. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S aqueous solution was mixed with MB (5 μM) and then heated in a water bath at different temperatures (25°C, 35°C, 45°C, 55°C and 65°C) for 15 min. After the reaction, the nanosheets were removed by centrifugation, and the characteristic absorption peak changes of MB at a wavelength of 665 nm were recorded using an ultraviolet spectrophotometer.

[0066] MB degradation test results are as follows Figure 4 As shown in the figure, from the UV-visible spectrum of MB degradation, it can be seen that with the increase of reaction temperature, the UV characteristic absorption peak of MB becomes weaker.

[0067] Figure 3 and Figure 4 The results show that the Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94)Se2S nanosheets can produce hydroxyl radicals to kill tumor cells.

[0068] 2. Singlet oxygen fluorescence probe (ABDA) degradation test

[0069] Different concentrations of Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S aqueous solutions (0 μg / mL, 62.5 μg / mL, 125 μg / mL, 250 μg / mL and 500 μg / mL) were mixed with ABDA (50 μM), heated in a water bath at 65 °C for 15 min, the nanosheets were removed by centrifugation, and the changes in the characteristic absorption peaks of ABDA at a wavelength of 400 nm were recorded using a UV spectrophotometer.

[0070] The results are as follows Figure 5 As shown, with Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )As the concentration of Se2S increases, the characteristic ultraviolet absorption peak of ABDA becomes weaker.

[0071] 500 μg / mL Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S aqueous solution was mixed with ABDA (50 μM) and then heated in a water bath at different temperatures (25°C, 35°C, 45°C, 55°C and 65°C) for 15 min. After the reaction, the nanosheets were removed by centrifugation, and the characteristic absorption peak changes of ABDA at a wavelength of 400 nm were recorded using an ultraviolet spectrophotometer.

[0072] The results are as follows Figure 6 As shown, from the UV-visible spectrum of ABDA degradation, it can be seen that as the temperature increases, the UV characteristic absorption peak of ABDA becomes weaker.

[0073] Depend on Figure 5 and Figure 6 The results show that the Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets can generate singlet oxygen to kill tumor cells.

[0074] 3. Nitroblue tetrazolium chloride (NBT) degradation test

[0075] Different concentrations of Cu 1.87 Ag 0.13 (Sr 0.06 Sn0.94 )Se2S aqueous solutions (0 μg / mL, 62.5 μg / mL, 125 μg / mL, 250 μg / mL, 500 μg / mL and 1 mg / mL) were mixed with NBT (50 μM), heated in a water bath at 65 °C for 15 min, the nanosheets were removed by centrifugation, and the changes in the characteristic absorption peaks of NBT at a wavelength of 560 nm were recorded using a UV spectrophotometer.

[0076] The results are as follows Figure 7 As shown in the UV-visible spectrum of NBT degradation, as Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )With the increase of Se2S concentration, the ultraviolet characteristic absorption peak of NBT becomes weaker.

[0077] The concentration of Cu was 1 mg / mL. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S aqueous solution was mixed with NBT (50 μM) and then heated in a water bath at different temperatures (25°C, 35°C, 45°C, 55°C and 65°C) for 15 min. After the reaction, the nanosheets were removed by centrifugation, and the characteristic absorption peak changes of NBT at a wavelength of 560 nm were recorded using an ultraviolet spectrophotometer.

[0078] NBT degradation test results are as follows Figure 8 As shown, from the UV-visible spectrum of NBT degradation, it can be seen that as the temperature increases, the UV characteristic absorption peak of NBT becomes weaker.

[0079] Figure 7 and Figure 8 The results show that the Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets can generate superoxide anion radicals to kill tumor cells.

[0080] 4. 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) degradation test

[0081] Different concentrations of Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94)Se2S (0 μg / mL, 25 μg / mL, 50 μg / mL, 100 μg / mL, 200 μg / mL, and 400 μg / mL) were mixed with 30 μL, 10 mM glutathione (GSH), respectively, and the temperature was raised to 65°C in a water bath and maintained for 15 min. Then, 10 μL, 3 mg / mL DTNB was added to the reaction system and reacted for 15 s. The nanosheets were removed by centrifugation, and the changes in the characteristic absorption peaks of DTNB at a wavelength of 412 nm were recorded using a UV spectrophotometer.

[0082] The results are as follows Fig. 9 As shown in the UV-visible spectrum of DTNB degradation, as Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )With the increase of Se2S concentration, the ultraviolet characteristic absorption peak of DTNB becomes weaker.

[0083] 30 μL of 10 mM GSH and 400 μg / mL Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S was heated to (25℃, 35℃, 45℃, 55℃ and 65℃) in a water bath and maintained for 15min. Then 10μL, 3mg / mL DTNB was added and reacted for 15s. The nanosheets were removed by centrifugation and the characteristic absorption peak changes of DTNB at a wavelength of 412nm were recorded using an ultraviolet spectrophotometer.

[0084] The results are as follows Fig.10 As shown, from the UV-visible spectrum of DTNB degradation, it can be seen that as the temperature increases, the UV characteristic absorption peak of DTNB becomes weaker.

[0085] Fig. 9 and Fig.10 The results showed that Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S nanosheets can consume glutathione when heated, and the highly expressed glutathione in the tumor will remove the generated ROS. The nanosheets prepared by the present invention amplify the oxidative damage by consuming glutathione, thereby enhancing the killing effect on tumor cells.

[0086] 5. Microwave response heating performance test

[0087] Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94)Se2S solution was microwaved in a microwave therapy apparatus (4W) for 1 min, stopped for 30 s, and irradiated for 30 s. The microwave-stop-irradiation procedure was repeated 3 times, and the temperature changes were recorded using a thermal imager during the whole process.

[0088] The microwave response heating performance test results are as follows Fig.11 As shown, Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S heating curve shows that Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) The microwave response temperature-raising ability of Se2S increases with the increase of its concentration, reaching the highest when its concentration is 1 mg / mL. After three cycles, the highest temperature of the 1 mg / mL treatment group can reach 48.4°C, the 0 mg / mL treatment group (pure water) is 40°C, the 100 μg / mL group and the 500 μg / mL group are 45.2°C and 46.1°C, respectively. Compared with 0 mg / mL, the temperature of the 1 mg / mL treatment group is 8.4°C higher, indicating that the nanosheets prepared by the present invention have good microwave response temperature-raising performance.

[0089] Comparative Example 1

[0090] This comparative example provides a preparation method of Cu2SnSe3 nanocrystals. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets are prepared by doping Cu2SnSe3 nanocrystals.

[0091] The preparation method of Cu2SnSe3 nanocrystals in this comparative example comprises the following steps:

[0092] Solution A: Dissolve diphenyl diselenide (2.3410 g, 7.5 mmol) in 30 mL of oleylamine (OAm) by ultrasonication at room temperature for about 15 minutes to prepare a diphenyl diselenide / OAm solution.

[0093] Solution B: CuCl (0.8910 g, 9 mmol), SnCl2.2H2O (0.6770 g, 3 mmol) and OAm (120 mL) were mixed in a 500 mL three-necked flask. Degased at room temperature for a few minutes, and then purged with N2 under magnetic stirring. Subsequently, the mixture was heated to 230 ° C, and solution A was quickly injected into the mixture. Finally, the mixture was heated to 240 ° C and kept warm for 30 min. After cooling naturally to room temperature, it was washed with ethanol and vacuum dried to obtain Cu2SnSe3 nanocrystals.

[0094] Cu2SnSe3 nanocrystals and Cu prepared in Example 1 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )The fluorescence spectrum of Se2S nanosheets is shown in Fig.12 As shown in Figure 2, the photoluminescence (PL) signal of semiconductor materials is caused by the recombination of photoinduced carriers. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S, it has obvious PL signal, indicating that Cu2SnSe3 causes serious recombination of carriers. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S is more conducive to the separation of carriers and improves the separation efficiency of carriers.

[0095] Example 2

[0096] This embodiment provides a Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S-BG composite scaffold, the preparation method thereof comprises the following steps:

[0097] S1: Prepare 10wt% polyvinyl alcohol sol with deionized water, heat and stir magnetically at 90°C, and rotate at 200-400rpm; mix the polyvinyl alcohol sol and BG scaffold powder in a mass ratio of 1:1.2 to obtain printing ink, and print it into a BG scaffold blank with a 3D printer. Dry the BG scaffold blank in a 60°C oven for 1h, and then calcine it at 1060°C in a muffle furnace for 3h to obtain a 3D printed BG scaffold.

[0098] S2: Soak the 3D printed BG scaffold in 1 mg / mL Cu prepared in Example 1. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets in water dispersion for 20 min, and then dried in an oven to obtain 3D printed Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S-BG composite scaffold.

[0099] The 3D printed BG scaffold prepared in step S1 was placed on the Cu 1.87 Ag 0.13 (Sr 0.06Sn 0.94 ) Se2S-BG composite scaffolds were digitally photographed and SEM photos at different magnifications were taken. Fig.13 As shown, Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets are uniformly loaded on the BG scaffold, making the composite scaffold grayish white.

[0100] The Cu prepared in step S2 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S-BG composite scaffold was subjected to elemental spectrum analysis, and the results were as follows Fig.14 As shown, it is further proved that Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets are uniformly loaded on the BG scaffold.

[0101] The Cu prepared in Example 1 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S nanosheets and the Cu prepared in this embodiment 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) The biological tests of Se2S-BG composite scaffold are as follows:

[0102] 1. Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Biocompatibility test of Se2S nanosheets

[0103] Detection of different Cu by CCK-8 method 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) The toxicity of Se2S nanosheets to cells, the specific experimental method is as follows:

[0104] Human umbilical vein endothelial cells (HUVEC) were seeded in 96-well plates (1.0×10 4 ) and cultured overnight. 100 μL of Cu at different concentrations (0 μg / mL, 50 μg / mL, 100 μg / mL, 200 μg / mL, 500 μg / mL and 800 μg / mL) diluted with culture medium was added to each well.1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets were incubated for 12 h and 24 h, respectively, and then 100 μL of culture medium containing 10 μL of CCK-8 solution was added. After incubation for 1 h, the absorbance of the cells at 450 nm was detected using a multifunctional microplate reader.

[0105] The cell activities after treatment with different concentrations and incubation for 12 h and 24 h were as follows Fig.15 As shown, different concentrations of Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets and human umbilical vein endothelial cells were co-incubated, and the cell activity was always maintained at a high level, indicating that the toxicity of the Cu1.87Ag0.13(Sr0.06Sn0.94)Se2S nanosheets of the present invention to cells is minimal. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets showed good biocompatibility.

[0106] 2. CCK-8 method to evaluate Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )The killing effect of Se2S nanosheets on tumor cells

[0107] KHOS cells were seeded in 96-well plates (1.0 × 10 4 ) and cultured overnight; KHOS cells were divided into the following 4 groups according to different treatment methods:

[0108] Control group (Control): add 100 μL of culture medium to the 96-well plate;

[0109] Microwave group (MWA): 100 μL of culture medium was added to the 96-well plate, and the 96-well plate was microwaved for 1 min in a microwave therapy apparatus, then stopped for 30 s, irradiated for 30 s, and the microwave-stop-irradiation procedure was repeated 3 times;

[0110] Nanosheet group (NPs): 100 μL of 100 μg / mL Cu diluted in culture medium was added to the 96-well plate. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets;

[0111] Microwave + nanosheet group (MWA + NPs): 100 μL of Cu diluted with culture medium at a concentration of 100 μg / mL was added to the 96-well plate. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets, and at the same time, the 96-well plate was microwaved in a microwave therapy apparatus for 1 min, stopped for 30 s, irradiated for 30 s, and the microwave-stop-irradiation procedure was repeated 3 times.

[0112] After the above treatments, the cells were incubated for 12 h and 24 h, respectively, and 100 μL of culture medium containing 10 μL of CCK-8 solution was added. After incubation for 1 h, the absorbance of the cells at 450 nm was detected using a multifunctional microplate reader.

[0113] The test results of incubation for 12h and 24h are as follows: Fig.16 and Fig.17 As shown, it can be seen that Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets can cooperate with microwave thermal therapy and have a relatively better inhibitory effect on tumor cell activity.

[0114] 3. The DCFH assay evaluates the ROS levels in tumor cells after treatment with different methods and evaluates the performance of differently treated tumor cells in producing ROS.

[0115] KHOS cells were divided into 4 groups (control group, microwave group, nanosheet group, microwave + nanosheet group) according to different treatment methods and seeded in 96-well plates (5.0×10 4 ) for 24 hours. Then, the cells were treated according to the above treatment methods. After 4 hours of incubation, 2',7'-dichlorodihydrofluoresceindiacetate (DCFH-DA) working solution was added and incubated in the dark for 30 minutes. Fig.18 As shown in the figure, the microwave + nanosheet group has obvious fluorescence and produces strong ROS. This result shows that under microwave irradiation, Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets can significantly increase the ROS level in tumor cells.

[0116] 4. Live / dead staining of KHOS cells and the killing effect of NPs on KHOS cells

[0117] The results are shown in Figure 2. Fig.19 As shown, compared with the NPs-treated group and the MWA-treated group, there was only a small amount of green fluorescence in the MWA+NPs-treated group, indicating that a large number of KHOS cells were killed, confirming the significant therapeutic effect of NPs-mediated microwave hyperthermia.

[0118] In addition, the apoptosis rate can be quantitatively analyzed by FCM analysis using the Annexin V-FITC / PI apoptosis detection kit, such as Fig. 20 Annexin is a Ca2+ with a molecular weight of 35-36KD. 2+ Dependent phospholipid binding protein, can bind with high affinity and specificity to phosphatidylserine (PS) on the surface of apoptotic cells. PI is a nucleic acid dye that cannot penetrate the cell membranes of living cells and early apoptotic cells, but can penetrate the cell membranes of late apoptotic cells and dead cells to dye the cell nucleus red. The flow apoptosis graph is divided into four parts, of which the Q4 quadrant (lower left) represents cells that have not undergone apoptosis (including healthy cells and cells that have not yet started the apoptotic process), the Q3 quadrant (lower right) represents early apoptotic cells, the Q2 quadrant (upper right) represents late apoptotic cells, and the Q1 quadrant (upper left) represents necrotic cells.

[0119] Fig. 20 The results showed that the cell apoptosis rate in the MWA-treated group was 22.2%, of which the early-acting rate was 9.23% and the late-acting rate was 13%. After combined with NPs, the cell apoptosis rate reached 90%, of which the early-acting rate was 73.7% and the late-acting rate was 16.3%, proving that NPs kill KHOS cells.

[0120] 5. Antibacterial effect test

[0121] The antibacterial effect test includes the following steps:

[0122] 1.1 Bacterial recovery

[0123] Take out the shaking tube and the streaked Staphylococcus aureus bacterial plate (4°C refrigerator) and place them on the clean workbench; add 3-5mL LB (bacterial culture medium) to the shaking tube, use a 1mL pipette tip to pick a colony from the bacterial plate and put it into the culture medium and blow to ensure that the colony is in the LB; put the shaking tube into the shaker and set the speed (140rpm~180rpm).

[0124] 1.2 Agar plate configuration

[0125] Prepare agar in advance and sterilize it: 350mL ultrapure water + 14g blood agar base; dispense the liquid agar into bacterial culture dishes on the clean bench, pouring about 1 / 3 of liquid agar into each dish; after pouring the agar, place the agar plate on the workbench vent to cool it down and allow it to solidify slowly; after the agar plate solidifies, cover it with a lid and turn it upside down (to prevent contamination by condensed water) and store it in a 4°C refrigerator.

[0126] 1.3 Bacterial plating

[0127] Prepare the revived Staphylococcus aureus, take 200 μL and place it in a 96-well plate and measure the absorbance using an ELISA reader (absorbance 0.1 = 10 8 CFU / ml), and diluted with PBS in a gradient manner to 10 8 CFU / mL; the material concentration was 200μg / ml, the control group (Control) mixed Staphylococcus aureus with PBS, and the intervention groups included nanosheets group (NPs), microwave treatment group (MWA), microwave treatment group + nanosheets group (MWA + NPs); the agar plate was taken out of the 4℃ refrigerator and marked on the lid;

[0128] The treatments of the NPs group, MWA group, and MWA+NPs group were as follows:

[0129] NPs group: 200 μg / ml Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S nanosheets aqueous dispersion and Staphylococcus aureus are mixed;

[0130] The MWA group was treated with microwave ablation of Staphylococcus aureus suspension. The specific operation was as follows: the Staphylococcus aureus suspension was microwaved for 1 min in a microwave therapy device, stopped for 30 s, irradiated for 30 s, and the microwave-stop-irradiation procedure was repeated 3 times;

[0131] MWA+NPs is a mixture of microwave ablation nanomaterials and Staphylococcus aureus; the specific operation is: 200 μg / ml Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) After the Se2S nanosheets aqueous dispersion was mixed with Staphylococcus aureus, it was placed in a microwave therapy apparatus for microwave treatment for 1 min, stopped for 30 s, irradiated for 30 s, and the microwave-stop-irradiation procedure was repeated 3 times.

[0132] Then, 10 sterilized glass beads were spread on the agar plate, and 100 μL of the treated control group and intervention group (NPs, MWA, MWA+NPs) was aspirated and dropped in the middle of the agar plate. The lid was closed, and the glass beads were shaken up and down to make the bacterial solution evenly distributed on the agar plate. After shaking for about 30 seconds, the glass beads were poured out and soaked in 75% ethanol. After a few minutes, the agar plate was inverted and placed in a 37°C incubator. After 24 hours of intervention, the colonies on the agar plates of different groups were photographed.

[0133] The results are as follows Fig.21As shown in the figure, in the MWA treatment group, the bacteria were not completely killed, indicating that MWA treatment has a certain antibacterial effect, but it is not enough to completely eliminate the bacteria. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S) combined use, the bacteria were almost completely killed, this result further proves that the Cu prepared by the present invention 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets also have excellent antibacterial effects.

Claims

1. A Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets, characterized in that The Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets have microwave thermal catalytic properties and microwave responsive heating properties.

2. A Cu as claimed in claim 1 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) A method for preparing Se2S nanosheets, characterized in that: The steps include: S1: dissolving diphenyl diselenide in oleylamine to form solution A; S2: Dissolve CuCl, AgNO3, SrCl2·6H2O, SnCl2·2H2O, and dodecanethiol in oleylamine to form solution B; S3: After degassing the solution B, heat it to 210°C to 250°C, add the solution A thereto and mix well, keep the temperature at 220°C to 260°C for 20 to 40 minutes, cool and centrifuge to obtain Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets.

3. According to claim 2 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) A method for preparing Se2S nanosheets, characterized in that: The mass concentration of diphenyl diselenide in the solution A is 78 mg / mL.

4. According to claim 2 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) A method for preparing Se2S nanosheets, characterized in that: The mass concentration of CuCl in the solution B is 7 mg / mL; the mass concentration of AgNO3 is 0.83 mg / mL; the mass concentration of SrCl2·6H2O is 0.4 mg / mL; the mass concentration of SnCl2·2H2O is 5.3 mg / mL; and the mass concentration of dodecanethiol is 12.5 wt%.

5. According to claim 2 Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) A method for preparing Se2S nanosheets, characterized in that: The volume ratio of solution A to solution B is 1:

4.

6. A kind of Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S-BG composite scaffold, characterized in that, The composite support includes a 3D printed BG support and a Cu supported on the 3D printed BG support. 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets, the Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )The mass ratio of Se2S nanosheets to the 3D printed BG scaffold is (0.5-4):

6.

7. A method for preparing the composite stent according to claim 6, characterized in that: The steps include: Immerse the BG support in the Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S nanosheets in water dispersion, and then taken out and dried to obtain Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Se2S-BG composite scaffold.

8. The preparation method according to claim 7, characterized in that: The Cu 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )The mass concentration of Se2S nanosheets in the aqueous dispersion is 0.1-1 mg / mL.

9. The preparation method according to claim 7 or 8, characterized in that: The BG scaffold is prepared by the following method: A 10wt% polyvinyl alcohol sol was prepared with deionized water, and magnetic stirring was performed while heating at 90°C and a rotation speed of 200-400rpm; the polyvinyl alcohol sol and the BG scaffold powder were evenly mixed at a mass ratio of 1:1.2 to obtain a printing ink, which was printed into a scaffold blank with a 3D printer; the obtained scaffold blank was first dried in an oven at 60°C for 1h, and then calcined in a muffle furnace at 1060°C for 3h to obtain a 3D printed BG scaffold.

10. The Cu according to claim 1 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 ) Se2S nanosheets or the Cu as claimed in claim 6 1.87 Ag 0.13 (Sr 0.06 Sn 0.94 )Application of Se2S-BG composite scaffold in the preparation of drugs for treating bone tumors or bone defect repair materials.